Phase II randomized trial comparing sequential first-line everolimus and second-line sunitinib versus first-line sunitinib and second-line everolimus in patients with metastatic renal cell carcinoma (Q41508355)
Jump to navigation
Jump to search
scientific article published on 21 July 2014
Language | Label | Description | Also known as |
---|---|---|---|
English | Phase II randomized trial comparing sequential first-line everolimus and second-line sunitinib versus first-line sunitinib and second-line everolimus in patients with metastatic renal cell carcinoma |
scientific article published on 21 July 2014 |
Statements
1 reference
Phase II randomized trial comparing sequential first-line everolimus and second-line sunitinib versus first-line sunitinib and second-line everolimus in patients with metastatic renal cell carcinoma (English)
1 reference
Carlos H Barrios
Tae Min Kim
Silvia Falcon
Thomas Cosgriff
W Graydon Harker
Vichien Srimuninnimit
Ken Pittman
Roberto Sabbatini
Thomas W Flaig
Ray Page
Sevil Bavbek
J Thaddeus Beck
Poulam Patel
Foon-Yiu Cheung
Sunil Yadav
Edward M Schiff
Xufang Wang
Julie Niolat
Dalila Sellami
Oezlem Anak
21 July 2014
1 reference